STAT3 and head and neck squamous cell carcinoma: Hayakawa et al. [32] found that IL-6 levels were upregulated in HNSCC, and elevated levels of IL-6 are associated with STAT3 signalling and blockage of DC maturation, which makes them a potential target for therapeutic inhibition.